CorMedix, Inc.
(NYSE Amex Equities : CRMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. 0.98%163.090.7%$520.18m
MDTMedtronic Plc 0.13%119.010.6%$396.86m
ABTAbbott Laboratories 0.83%89.010.8%$362.86m
ISRGIntuitive Surgical, Inc. 0.29%600.032.4%$362.07m
TMOThermo Fisher Scientific, Inc. 0.71%339.141.0%$288.79m
BSXBoston Scientific Corp. 2.50%44.281.1%$284.80m
BDXBecton, Dickinson & Co. 0.08%277.091.1%$261.39m
SYKStryker Corp. 1.25%212.081.3%$248.97m
ABMDABIOMED, Inc. -0.09%181.283.3%$209.66m
EWEdwards Lifesciences Corp. -0.05%238.461.2%$209.38m
BAXBaxter International, Inc. -0.29%89.731.8%$205.14m
ALGNAlign Technology, Inc. -1.52%280.706.4%$195.31m
STESTERIS Plc (Ireland) -0.06%154.043.7%$171.56m
DXCMDexCom, Inc. -1.54%230.798.3%$168.83m
NVSTEnvista Holdings Corp. 0.25%32.020.0%$142.47m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.